Literature DB >> 429488

Gynecomastia as a physical finding in normal men.

F Q Nuttall.   

Abstract

The prevalence of palpable gynecomastia was determined in 306 normal adult men ranging in age from 17-58 yr. Palpable breast tissue was present in 36% and was bilateral in all but 7 subjects. In the great majority of cases, the gynecomastia was 4 cm or less in diameter. A diameter greater than 5 cm was distinctly unusual. With advancing age there was a progressive increase in the prevalence of gynecomastia. This increase was most striking in those over the age of 44 and in the 20- to 24-yr-old group compared to those 19 yr old or less. In those over the age of 44, the prevalence was 57%. These data indicate that palpable gynecomastic is common in normal adult men. This high prevalence must be taken into consideration when attributing gynecomastia to a drug or disease state.

Entities:  

Mesh:

Year:  1979        PMID: 429488     DOI: 10.1210/jcem-48-2-338

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

1.  Gynecomastia.

Authors:  Frank Q Nuttall
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

2.  The Diagnostic Accuracy of Mammography and Ultrasound in the Evaluation of Male Breast Disease: A New Algorithm.

Authors:  Zehra H Adibelli; Ozgur Oztekin; Hakan Postaci; Adam Uslu
Journal:  Breast Care (Basel)       Date:  2009-08-03       Impact factor: 2.860

3.  Evaluation of breast enlargement in young males and factors associated with gynecomastia and pseudogynecomastia.

Authors:  M Yazici; M Sahin; E Bolu; D E Gok; A Taslipinar; S Tapan; D Torun; G Uckaya; M Kutlu
Journal:  Ir J Med Sci       Date:  2009-06-04       Impact factor: 1.568

Review 4.  Gynaecomastia and breast cancer in men.

Authors:  Catherine B Niewoehner; Anna E Schorer
Journal:  BMJ       Date:  2008-03-29

5.  Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study.

Authors:  Srihari Gopal; Rosanne Lane; Isaac Nuamah; Margaret Copenhaver; Jaskaran Singh; David Hough; Mark Bach; Adam Savitz
Journal:  CNS Drugs       Date:  2017-09       Impact factor: 5.749

Review 6.  Gynaecomastia--pathophysiology, diagnosis and treatment.

Authors:  Harmeet S Narula; Harold E Carlson
Journal:  Nat Rev Endocrinol       Date:  2014-08-12       Impact factor: 43.330

7.  Prepubertal unilateral gynecomastia in the absence of endocrine abnormalities.

Authors:  Min Kang; Chan Jae Lee; Il Tae Hwang; Kwanseop Lee; Min Jae Kang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-09-30

8.  Sexual dimorphisms in the associations of BMI and body fat with indices of pubertal development in girls and boys.

Authors:  Melissa K Crocker; Elizabeth A Stern; Nicole M Sedaka; Lauren B Shomaker; Sheila M Brady; Asem H Ali; Thomas H Shawker; Van S Hubbard; Jack A Yanovski
Journal:  J Clin Endocrinol Metab       Date:  2014-04-29       Impact factor: 5.958

9.  Epidemic of gynecomastia among illegal Haitian entrants.

Authors:  R W Sattin; A Roisin; M E Kafrissen; J B Dugan; L S Farer
Journal:  Public Health Rep       Date:  1984 Sep-Oct       Impact factor: 2.792

10.  Management options for gynaecomastia and breast pain associated with nonsteroidal antiandrogen therapy : case report series.

Authors:  I Leibovitch; D Gillatt; P Hopwood; P Iversen; R E Mansel; D McLeod; R Vela-Navarrete; P Richaud; W See; C Tyrrell; M Wirth
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.